Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03378336 · ClinicalTrials.gov registry record
Psoriatic Arthritis Research Collaborative: Biologic Sub-Study
A clinical trial of Psoriatic Arthritis, sponsored by University of Pennsylvania.
- Completed
- Registry status
- 171
- Enrollment target
- 4
- Study locations
NCT03378336 is a study of Psoriatic Arthritis that has completed, run by University of Pennsylvania. The registered enrollment target is 171 participants, below the 849-participant average among 48 other Psoriatic Arthritis trials with a reported enrollment target (80% lower). The trial reports 4 study locations across 4 states.
The verdict
NCT03378336, a study of Psoriatic Arthritis, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- 171 participants
- Enrollment target
- 4
- Study locations
Study Summary
Psoriatic arthritis (PsA) is an inflammatory arthritis with substantial variation in clinical features. We propose a multicenter collaborative approach to better understand the phenotypes and current management of PsA in the United States.The central goal of this proposal is to obtain the data necessary to design a pragmatic trial in PsA.
Conditions Studied
Study Locations (4)
New York
- NYU School of Medicine - New York
Ohio
- Cleveland Clinic - Cleveland
Pennsylvania
- Hospital at the University of Pennsylvania - Philadelphia
Utah
- University of Utah - Salt Lake City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 171 participants |
| Start Date | 2017-12-31 |
| Est. Completion | 2023-08-16 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03378336
The ClinicalTrials.gov registry entry for NCT03378336 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 171 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 849-participant average among 48 other Psoriatic Arthritis trials with a reported enrollment target (80% lower). The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Psoriatic Arthritis appearing as the primary indexed condition, and to 0 interventions.
NCT03378336 reports 4 study locations spanning 4 distinct geographic areas - top geographies include New York, Ohio, Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT03378336 about?
NCT03378336 is a clinical study titled "Psoriatic Arthritis Research Collaborative: Biologic Sub-Study". Psoriatic arthritis (PsA) is an inflammatory arthritis with substantial variation in clinical features. We propose a multicenter collaborative approach to better understand the phenotypes and current management of PsA in the United States.The central goal of this proposal is to obtain the data neces...
What is the current status of trial NCT03378336?
This trial is currently completed. The enrollment target is 171 participants. The study started on 2017-12-31. Estimated completion is 2023-08-16.
What conditions does trial NCT03378336 study?
This clinical trial studies the following conditions: Psoriatic Arthritis.
Who is sponsoring clinical trial NCT03378336?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03378336 being conducted?
This trial has 4 study locations across New York, Ohio, Pennsylvania, Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Psoriatic Arthritis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Stelara and Tremfya Pregnancy Exposure Registry OTIS Autoimmune Diseases in Pregnancy Project
RECRUITING
-
Rheumatology Diet Study
RECRUITING
-
Nivolumab in Treating Patients With Autoimmune Disorders and Advanced, Metastatic, or Unresectable Cancer
RECRUITING · Phase 1
-
Stronger Together Psoriatic Arthritis Wellness Study
RECRUITING
-
A Study to Assess the Concentration of Bimekizumab in Mature Breast Milk From Mothers Receiving Treatment With Bimzelx® (Bimekizumab)
RECRUITING · Phase 1
-
Creating Health Course Study for People With Rheumatological Conditions
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.